CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +17,080 | $2.98 | $51K | 195,588,674 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +31,420 | $2.98 | $94K | 195,620,094 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +12,975 | $2.99 | $39K | 195,633,069 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +27,600 | $2.99 | $83K | 195,660,669 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +11,630 | $3.00 | $35K | 195,672,299 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +7,370 | $3.00 | $22K | 195,679,669 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +7,223 | $3.01 | $22K | 195,686,892 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +19,902 | $3.01 | $60K | 195,706,794 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +3,577 | $3.02 | $11K | 195,710,371 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +12,700 | $3.02 | $38K | 195,723,071 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +14,023 | $3.03 | $42K | 195,737,094 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +13,200 | $3.03 | $40K | 195,750,294 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +6,000 | $3.04 | $18K | 195,756,294 |
| 2022-05-13 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +400 | $3.04 | $1K | 195,756,694 |
| 2022-05-12 | Nabel Gary J. Chief Innovation Officer | Purchase | +6,979 | $2.65 | $18K | 6,979 |
| 2022-05-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +400,000 | $2.83 | $1.1M | 195,556,694 |
| 2022-05-10 | Zerhouni Elias A. Vice Chairman and President | Purchase | +89,600 | $2.79 | $250K | 89,600 |
| 2022-05-10 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +400,000 | $2.78 | $1.1M | 195,156,694 |
| 2022-05-09 | Nabel Gary J. Chief Innovation Officer | Grant or award | +19,777,514 | 19,777,514 | ||
| 2022-05-09 | Nabel Gary J. Chief Innovation Officer | Grant or award | +19,777,514 | 19,777,514 |
Page 24 of 33 · 653 trades